[{"client_msg_id":"28cd6f0e-6e68-4de6-8aa2-9db124a16255","type":"message","text":"This is big: <https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval>","user":"U8JP5B9T2","ts":"1612370443.100600","team":"T68168MUP","attachments":[{"title":"Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose | University of Oxford","title_link":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval","text":"Analyses reveal single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month periodAfter the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK. (82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks)Data supports the 4-12 week prime-boost dosing interval recommended by many global regulatorsAnalyses of PCR positive swabs in UK population suggests vaccine may have substantial effect on transmission of the virus with 67% reduction in positive swabs among those vaccinated","fallback":"Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose | University of Oxford","image_url":"https://www.ox.ac.uk/sites/files/oxford/field/field_image_main/Oxford_University_Covid_Vaccine_by_John_Cairns_25.6.20-296%20%281%29.jpg","from_url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval","image_width":375,"image_height":250,"image_bytes":1740524,"service_icon":"https://www.ox.ac.uk/sites/default/themes/custom/oxweb/apple-touch-icon-114x114.png","service_name":"ox.ac.uk","id":1,"original_url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval"}],"blocks":[{"type":"rich_text","block_id":"hHw3D","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"This is big: "},{"type":"link","url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval"}]}]}],"thread_ts":"1612370443.100600","reply_count":15,"reply_users_count":5,"latest_reply":"1612379697.106300","reply_users":["U8JP5B9T2","U8MPCDJAY","U8D9768Q6","U6A936746","U01CQTKB86N"],"subscribed":false,"reactions":[{"name":"bangbang","users":["UH24GRBLL","U6795JH6H","U8MPCDJAY"],"count":3}]},{"client_msg_id":"7ca75e86-89ae-46e6-b72e-3bf7c2a97461","type":"message","text":"I suspect we'll see similar things with the Moderna vaccine too. I mean, this is what I expected, but nice to have confirmation.","user":"U8JP5B9T2","ts":"1612372116.101300","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"Tnc4","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"I suspect we'll see similar things with the Moderna vaccine too. I mean, this is what I expected, but nice to have confirmation."}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"EABC5358-A12E-49A5-BDB9-A5BA0FE1CE53","type":"message","text":":crossed_fingers:Do you think there’s any reason to not see this for the mRNA ones too?","user":"U8MPCDJAY","ts":"1612372164.102300","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"oLa","elements":[{"type":"rich_text_section","elements":[{"type":"emoji","name":"crossed_fingers"},{"type":"text","text":"Do you think there’s any reason to not see this for the mRNA ones too?"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"86c09151-87db-4172-b773-189cf8f95266","type":"message","text":"Yeah, it would be much more surprising if viral loads and transmission *didn't* decrease with vaccination. I think a lot of scientists were just being super cautious with predicting that","user":"U8JP5B9T2","ts":"1612372278.102600","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"VlH","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Yeah, it would be much more surprising if viral loads and transmission "},{"type":"text","text":"didn't","style":{"bold":true}},{"type":"text","text":" decrease with vaccination. I think a lot of scientists were just being super cautious with predicting that"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"43beaca4-7be5-4635-b4a6-da9e5a8540c7","type":"message","text":"because they don't trust people to continue to observe good public health practice after being vaccinated? I don't really know","user":"U8JP5B9T2","ts":"1612372315.102800","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"ugi","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"because they don't trust people to continue to observe good public health practice after being vaccinated? I don't really know"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"9F6ED24C-96FC-4019-87AE-A0CD1387100D","type":"message","text":"Maybe it’s just an uncomfortable shift from the norm, to do trials and stick to what’s been tested","user":"U8MPCDJAY","ts":"1612372702.103800","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"2JPji","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Maybe it’s just an uncomfortable shift from the norm, to do trials and stick to what’s been tested"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"c42ebc2e-4105-47e4-a024-0b7e154a3638","type":"message","text":"Probably less about the public and more about policy makers. You really don't want governments to decide \"Okay, we're just going to give everyone one dose instead of two\", when that wasn't the thing that was studied or approved.","user":"U8D9768Q6","ts":"1612373385.104200","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"ino1G","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Probably less about the public and more about policy makers. You really don't want governments to decide \"Okay, we're just going to give everyone one dose instead of two\", when that wasn't the thing that was studied or approved."}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"6da0e93f-701f-4365-9743-61a56fe530f8","type":"message","text":"Wasn't there some indications from Israel that single doses of the mRNA vaccine weren't giving very much protection?","user":"U8D9768Q6","ts":"1612373433.104400","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"nBGe","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Wasn't there some indications from Israel that single doses of the mRNA vaccine weren't giving very much protection?"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"90fcbdad-244b-4f17-8f42-2392fd7d6483","type":"message","text":"I was mostly referring to the reduction in transmission. I agree that the one-vs-two doses thing is more about policy makers.","user":"U8JP5B9T2","ts":"1612374493.104600","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"vkXNA","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"I was mostly referring to the reduction in transmission. I agree that the one-vs-two doses thing is more about policy makers."}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"c2116753-9215-48f9-a9cc-b11076c3e9c0","type":"message","text":"Decisions around dosing are also really  dependent on how vaccines affect transmission. Eg if there was no effect on transmission, I would advocate single dose to reduce the disease burden as widely as possible. But if we can actually cut of transmission vectors, that will have a much bigger effect much sooner","user":"U8JP5B9T2","ts":"1612374632.104800","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"edG9=","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Decisions around dosing are also really  dependent on how vaccines affect transmission. Eg if there was no effect on transmission, I would advocate single dose to reduce the disease burden as widely as possible. But if we can actually cut of transmission vectors, that will have a much bigger effect much sooner"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"110644ec-59a7-47b0-ba96-50fdebfa0ff4","type":"message","text":"I have seen suggestion that that study was of limitted value.\nAs the sample pool was primarily consisting of healthcare workers.\nWho are baised towards the younger-end, middle-class, white, and female.","user":"U6A936746","ts":"1612376171.105000","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"g3pb","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"I have seen suggestion that that study was of limitted value.\nAs the sample pool was primarily consisting of healthcare workers.\nWho are baised towards the younger-end, middle-class, white, and female."}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"0ddcca73-d4c8-4f08-88bf-9b8fa1b4cab1","type":"message","text":"Which study?","user":"U8D9768Q6","ts":"1612376198.105200","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"Enp=0","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"Which study?"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"fb27bd7c-ebca-4e58-a333-217942390034","type":"message","text":"The one that the top link pres-release is about\n<https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval>","user":"U6A936746","ts":"1612377092.105400","team":"T68168MUP","attachments":[{"title":"Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose | University of Oxford","title_link":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval","text":"Analyses reveal single standard dose efficacy from day 22 to day 90 post vaccination of 76% with protection not falling in this three-month periodAfter the second dose vaccine efficacy from two standard doses is 82.4% with the 3-month interval being used in the UK. (82.4% effective, with a 95% confidence interval of 62.7% - 91.7% at 12+ weeks)Data supports the 4-12 week prime-boost dosing interval recommended by many global regulatorsAnalyses of PCR positive swabs in UK population suggests vaccine may have substantial effect on transmission of the virus with 67% reduction in positive swabs among those vaccinated","fallback":"Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose | University of Oxford","image_url":"https://www.ox.ac.uk/sites/files/oxford/field/field_image_main/Oxford_University_Covid_Vaccine_by_John_Cairns_25.6.20-296%20%281%29.jpg","from_url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval","image_width":375,"image_height":250,"image_bytes":1740524,"service_icon":"https://www.ox.ac.uk/sites/default/themes/custom/oxweb/apple-touch-icon-114x114.png","service_name":"ox.ac.uk","id":1,"original_url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval"}],"blocks":[{"type":"rich_text","block_id":"3Nb","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"The one that the top link pres-release is about\n"},{"type":"link","url":"https://www.ox.ac.uk/news/2021-02-02-oxford-coronavirus-vaccine-shows-sustained-protection-76-during-3-month-interval"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"},{"client_msg_id":"e641a00b-cb57-487c-92d3-276b817e18db","type":"message","text":"If the controls are done right, it's still pretty important. There's no reason to think that reductions in transmissibility won't translate to other demographics.\n\nRemember that 67% decrease in positve swabs probably means much larger decreases in transmissibility, since the remaining positive swabs probably have much lower viral loads","user":"U8JP5B9T2","ts":"1612377265.105700","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"nXP","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"If the controls are done right, it's still pretty important. There's no reason to think that reductions in transmissibility won't translate to other demographics.\n\nRemember that 67% decrease in positve swabs probably means much larger decreases in transmissibility, since the remaining positive swabs probably have much lower viral loads"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2","reactions":[{"name":"+1","users":["U6A936746"],"count":1}]},{"client_msg_id":"ecb9e73e-8928-4562-9204-f1abb9a9e6c3","type":"message","text":"I should probably clarify that when I say \"translate to other demographics\" I mostly mean the effect, rather than the magnitude. But for these early studies, I sort of mentally put 20% confidence band around any of the point estimates","user":"U8JP5B9T2","ts":"1612378572.106000","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"HEQZ","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"I should probably clarify that when I say \"translate to other demographics\" I mostly mean the effect, rather than the magnitude. But for these early studies, I sort of mentally put 20% confidence band around any of the point estimates"}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2","reactions":[{"name":"+1","users":["U6A936746"],"count":1}]},{"client_msg_id":"fbd3c0c3-0d85-49e6-aeb8-e7f15f16d814","type":"message","text":"That’s good news. I’m more likely to get this Oxford-AstraZeneca vaccine than either of the mRNA ones as Finland is prioritising giving the mRNA vaccines to 70+ year olds.. or was it 65+.","user":"U01CQTKB86N","ts":"1612379697.106300","team":"T68168MUP","blocks":[{"type":"rich_text","block_id":"qsa9","elements":[{"type":"rich_text_section","elements":[{"type":"text","text":"That’s good news. I’m more likely to get this Oxford-AstraZeneca vaccine than either of the mRNA ones as Finland is prioritising giving the mRNA vaccines to 70+ year olds.. or was it 65+."}]}]}],"thread_ts":"1612370443.100600","parent_user_id":"U8JP5B9T2"}]